Steve Courmanopoulos, Senior Partner
Steve obtained his psychological training at McGill (B.Sc.), California State (M.A.), and Capella Universities (Ph.D. Psych – cnd). After several years working in a clinical setting he returned to McGill to pursue graduate studies in business. His principal area of interest is how company culture drives individual behaviour and corporate performance.
After more than thirty-five years of work experience and hundreds of consulting projects, Steve believes that the one factor that truly differentiates companies that produce long-term shareholder value is the ability to engage their employees’ passion to the company’s mission and vision. This “human element” of corporate performance is the least well understood, despite its critical impact on corporate performance.
Angelo Mylonakis, Senior Partner
Angelo holds an MBA from the Richard Ivey School of Business at the University of Western Ontario and a Diploma in Institutional (Hospital) Administration from Concordia University.
His corporate career includes Sales with BDH/E.Merck, Sales Management at Hill-Rom, and General Management with Terumo Corporation (Canada) for which he was responsible from 1994-2000.
Steve Arless, Partner
Mr. Arless served CryoCath Technologies Inc. as President and Chief Executive Officer from a start-up in April 1996 to July 2006. CryoCath gained worldwide recognition as the leading technology company developing therapeutic catheter ablation solutions for atrial fibrillation, a pervasive cardiac arrhythmia. Supported by aggressive financing strategies including a record IPO of $45 MM in October 2000, worldwide sales grew to over $40 MM, with over 65% coming from the USA. Recently, Medtronic Inc. of Minneapolis, Minnesota, announced the acquisition of CryoCath, listed and traded on the TSE, for $400 million.
Mr. Arless has accumulated more than 35 years of extensive Canadian and international experience in the development, marketing and sales of medical devices products, including 17 years at Smith & Nephew Inc., where he served as President for close to five years. His experience includes extensive involvement in technology transfer and strategic acquisition projects across the United States and Canada and numerous international marketing mandates in the areas of orthotics, prosthetics, orthopaedics, wound care and durable medical equipment.
Mr. Arless’s most recent award, in October, 2005, was as Ernst and Young (Canada) Entrepreneur of the Year in healthcare.
